Latest Breaking News On - மேட் ஹெவிட் - Page 1 : comparemela.com

Ligand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript

Operator Good day and thank you for standing by. Welcome to the Ligand Pharmaceuticals Second Quarter Earnings Call. At this time all participants are in a listen-only mode. After the speaker s presentation there will be a question and answer session. [Operator Instructions] I would now like to hand the conference over to your first speaker today the Head of Investor Relations, Mr. Simon Latimer. Please go ahead sir. Simon Latimer Head of Investor Relations Thank you. Welcome to Ligand s second quarter of 2021 financial results and business update conference call. Our speakers for today s call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO.

United statesSan francisco bayStanford universitySan diegoSan franciscoMatt hewittJoseph pantginisJacob johnsonLawrence solowSimon latimerMatt korenbergMatthew foehrMatt foehrJacob johnson stephensBalaji prasad barclaysJohn higgins

Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript

Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesClifton parkMatt hewittDan arias stifelJohn kregerDan ariasPaul knight keybancRam selvarajuBrandon couillard jefferiesJon snodgresPaul knightBrandon couillardSondra newmanJulia qinJacob johnson

Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript

Simulations Plus, inc (SLP) Q3 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Simulations Plus, inc (NASDAQ: SLP) Q3 2021 Earnings Call Operator Greetings and welcome to the Simulations Plus Third Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Brian Siegel from Hayden IR. Thank you Mr. Siegel. You may begin.SPONSORED: 10 stocks we like better than Simulations Plus, Inc. When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

United statesFrance generalNorth carolinaMatt hewittRaymond jamesShawn oconnorWalt woltoszFrancois briseboisDane leone raymond jamesDane leoneFrancois brisebois oppenheimerBrian siegelExchange commissionMatthew hewitt craig hallum capital groupYour serviceSimulations plus inc

Simulations Plus, Inc (NASDAQ:SLP) - Simulations Plus Target Price Lowered At Craig-Hallum, Raymond James After Q3 Sales Miss Expectations

Simulations Plus, Inc (NASDAQ:SLP) - Simulations Plus Target Price Lowered At Craig-Hallum, Raymond James After Q3 Sales Miss Expectations
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Matt hewittDane leoneRaymond jamesSimulations plus incSimulations plusமேட் ஹெவிட்டேன் லியோன்ரேமஂட் ஜேம்ஸ்உருவகப்படுத்துதல்கள் ப்லஸ் இன்க்உருவகப்படுத்துதல்கள் ப்லஸ்

Avid Bioservices, Inc (CDMO) Q4 2021 Earnings Call Transcript

Operator Good day, ladies and gentlemen and welcome to the Avid Bioservices Fourth Quarter Fiscal 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call may be recorded. I would now like to hand the conference over to Tim Brons of Avid s Investor Relations Group. Please go ahead. Tim Brons Executive Vice President, Vida Strategic Partners, Inc. Thank you. Good afternoon and thank you for joining us. On today s call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and Timothy Compton, Chief Commercial Officer. Today we will be providing an overview of Avid Bioservices contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended April 30th, 2021. After our prepared remarks, we will welcome your questions.

Matt hewittJacob johnsonNicholas greenTimothy comptonDan hartPaul knight keybancTim bronsDaniel hartNick greenThomas kelliherPaul knightExchange commissionAvid bioservices incLucas baranowski craig hallum capital groupStephens incAvid investor relations group